Recurrence of gestational diabetes in primiparous women

Acta Obstetricia Et Gynecologica Scandinavica
Anne R KruseHanne Benedicte Wielandt

Abstract

Gestational diabetes mellitus (GDM) increases the risk for diabetes in the next pregnancy and later in life. Thus, estimating the risk of GDM in further pregnancies provides a time frame for possible preventive measures. We aimed to calculate the recurrence rate of GDM in primiparous women and evaluate the factors involved such as age, body mass index, weight gain, time between pregnancy and postpartum OGTT results. We established a prospective cohort during a 5-year period at the Department of Obstetrics at Kolding Hospital. Women with diet-treated GDM in their first pregnancy and a subsequent pregnancy constituted our study population. Multiparity and insulin-treated GDM were exclusion criteria. Among 15 735 deliveries, 535 women were diagnosed with GDM (3.4%). Of these, 209 (39.1%) were nulliparous women, treated with diet only. Seventy-two of these women had a subsequent pregnancy and they all attended the recommended screening procedure, a 75-g oral glucose tolerance test at 14-20 (early) or 27-30 (late) weeks' gestation. The recurrence rate of GDM was 47.2%. The risk of recurrence was less in women who lost weight between the first and the subsequent pregnancy. Recurrence of diet-treated GDM was 47.2% in primiparous women...Continue Reading

References

Oct 28, 1998·American Journal of Obstetrics and Gynecology·C A MajorM A Morgan
Sep 28, 2002·Diabetes Care·Catherine KimRobert H Knopp
Nov 28, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Yvonne LinnéStephan Rössner
Feb 10, 2007·Diabetes Care·Catherine KimShadi Chamany
Apr 10, 2007·Diabetes Care·Susan Y ChuPatricia M Dietz
Feb 27, 2008·Diabetes Care·Thomas A BuchananRichard Watanabe
May 9, 2008·The New England Journal of Medicine·UNKNOWN HAPO Study Cooperative Research GroupDavid A Sacks
Jan 20, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Peter Damm
Jun 9, 2009·Obstetrics and Gynecology Clinics of North America·Erica P Gunderson
Oct 7, 2009·American Journal of Perinatology·Heather J HolmesBrian M Casey
Apr 3, 2010·BMJ : British Medical Journal·Karl HorvathAndrea Siebenhofer
Apr 17, 2010·American Journal of Public Health·Shin Y KimPatricia Dietz
May 25, 2011·Obstetrics and Gynecology·Samantha F EhrlichAssiamira Ferrara
Jul 22, 2011·Obstetrics and Gynecology·Per OvesenUlrik Kesmodel
Dec 16, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·A A A M J DjelantikT G M Vrijkotte
Jul 13, 2012·Scandinavian Journal of Public Health·Eva AnderbergKerstin Berntorp
Apr 23, 2013·Acta Obstetricia Et Gynecologica Scandinavica·Azadeh HoushmandPeter Damm

❮ Previous
Next ❯

Citations

Apr 3, 2019·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Vincent W WongBin Jalaludin
Oct 30, 2019·BMC Pregnancy and Childbirth·Noor E W D TeulingsAngela M Wood
Jul 19, 2020·International Journal of Molecular Sciences·Emilyn U AlejandroMaria Ruth B Pineda-Cortel
Jul 5, 2018·Archives of Gynecology and Obstetrics·Liran HierschUNKNOWN for DOH-NET (Diabetes, Obesity and Hypertension in Pregnancy Research Network) and SOON (Southern Ontario Obstetrical Networ
Dec 2, 2017·Acta Obstetricia Et Gynecologica Scandinavica·Merja K LaineJohan G Eriksson
Jan 12, 2021·The Journal of Obstetrics and Gynaecology Research·Mamoru MorikawaHidemichi Watari
Oct 26, 2021·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Taniya S NagpalNicola Heslehurst

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Yukari KugishimaNobuko Kusuda
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Ebru TarimCantekin Iskender
© 2021 Meta ULC. All rights reserved